COVID-19 Neutralizing Antibody Rapid Test Kit (Colloidal Gold)

Tsanangudzo Pfupi

Product Detail

Chinangwa Kushandisa:

◆Zvekuonekwa kwemasoja ekudzivirira chirwere.

◆COVID-19 Neutralizing Antibody Rapid Test Kit (Colloidal Goridhe) ndeye lateral kuyerera immunoassay inotarisira kutariswa kwemhando yekudzivirira antibody yeSARS-CoV-2 muropa remunhu rose, serum kana plasma serubatsiro muAvaluation mazinga eanopesana nevanhu. -novel coronavirus neutralizing antibody titer.

Sampling nzira

◆Ropa Rakazara, Serum, Plasma

Working Principle:

◆Iyi kit inoshandisa immunochromatography.Kadhi rekuyedza rine: 1) colloidal goridhe-yakanyorwa recombinant novel coronavirus S-RBD antigen uye mhando yekudzora antibody goridhe mamaki;2) mutsara wekutsvaga (T line) uye imwe yehutano Kudzora mutsara (C line) ye nitrocellulose membrane.Mutsetse weT haufambiswe neHuman ACE2 protein yekuona novel coronavirus neutralizing antibody uye mutsetse weC haufambiswe nemhando yekudzivirira antibody.

◆ Kana chiyero chakakodzera chemuenzaniso wekuedza chakawedzerwa kune gomba remuenzaniso wekadhi rekuedza, muenzaniso uchaenderera mberi nekadhi rekuedza pasi pechiito che capillary.Kana sampuli iine novel coronavirus neutralizing antibody, antibody inosunga kune colloidal goridhe-yakanyorwa novel coronavirus antigen.Iyo yakasara yegoridhe-yakanyorwa novel coronavirus antigen mune immune complex ichabatwa nemunhu ACE2 protein isingafambi.

iyo membrane kuita mutsara wepepuru-tsvuku T, kusimba kwe t line Inversely proportional kusvika kuhuwandu hwemasoja ekudzivirira chirwere.

◆Kadhi yekuedza inewo mutsara wehutano hwehutano C . Fuchsia quality control line C inofanira kuonekwa pasinei nokuti mutsara wekuedza unowanikwa.Kana iyo yemhando yekudzora mutsara C ikasaoneka, mhedzisiro yebvunzo haina kunaka, uye sampuro inoda kuongororwa zvakare neimwe kadhi rekuyedza.

Ruzivo rwechigadzirwa:

◆Severe acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2, kana 2019-nCoV) hutachiona hweRNA hwakaputirwa husina-chikamu.Ndiyo

chikonzero cheCOVID-19, icho chinotapukira muvanhu.

◆SARS-CoV-2 ine akati wandei mapuroteni anosanganisira spike (S), hamvuropu (E), membrane (M) uye nucleocapsid (N).Iyo spike protein (S) ine receptor binding domain (RBD), iyo ine basa rekuziva iyo cell surface receptor, maantigen mukushandura enzyme-2 (ACE2).Inowanikwa uman ACE2 receptor inotungamira kune endocytosis mumaseru anotambira emukati memapapu uye hutachiona kudzokorora.

◆Kubatwa nejekiseni reSARS-CoV-2 kana SARS-COV-2 Vaccine kunotanga mhinduro yekudzivirirwa kwezvirwere zvemuviri kuti igadzire masoja ekudzivirira chirwere anodzivirira kutapukirwa nehutachiona.Masoja ekudzivirira ekudzivirira emunhu anonangana neanotambira ACE2 receptor-binding domain (RBD) yeSAR-COV-2 spike protein inoratidza inovimbisa kurapa uye kushanda nesimba kudzivirira.

◆Serum kana plasma muenzaniso/ropa remunwe.

◆Kuona semi-quantitative yekudzivirira masoja ekudzivirira chirwere.

◆ Neutralizing antibody test inogona kuona kana paine masoja ekudzivirira chirwere anorwisa SARS-CoV-2 mumuviri.

◆Batsira kuronda hupenyu hurefu hwekudzivirirwa kwekudzivirira mushure mekubaiwa.